Towards Novel BIOmarkers to Diagnose SEPsis on the Emergency Room
Status: Recruiting
Location: See all (3) locations...
Intervention Type: Other
Study Type: Observational
SUMMARY
Objectives: 1. To compare the immune response of patients with or without sepsis presenting to the ED with a(n) (suspected) infection. 2. To determine immune response aberrations that are associated with an increased risk of developing sepsis in patients presenting to the ED with a(n) (suspected) infection without sepsis. 3. To determine the long term cognitive and physical sequelae of sepsis after admission.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:
• Age 18 years or higher
• Presentation at the Emergency Department (ED)
• Clinical suspicion of infection or earlier confirmed infection
• Modified Early Warning Score (MEWS) of 2 or higher
Locations
Other Locations
Netherlands
Flevoziekenhuis
NOT_YET_RECRUITING
Almere Stad
Amsterdam UMC, location AMC
RECRUITING
Amsterdam
Amsterdam UMC, location VUMC
RECRUITING
Amsterdam
Contact Information
Primary
Oren Turgman, MD, MsC
biosep@amsterdamumc.nl
0205669111
Backup
Evelien Reijnders, MD, MsC
biosep@amsterdamumc.nl
0205669111
Time Frame
Start Date: 2022-10-25
Estimated Completion Date: 2026-10-01
Participants
Target number of participants: 3300
Treatments
Patients with infection
Patients with an (suspected) infection and a MEWS score 2 or higher
Related Therapeutic Areas
Sponsors
Leads: Amsterdam University Medical Centers (UMC), Location Academic Medical Center (AMC)
Collaborators: Amsterdam UMC, location VUmc, Flevoziekenhuis